CTNMCONTINEUM THERAPEUTICS INC-A
CUSIP 21217B100 · common stock
1 tracked investor held CONTINEUM THERAPEUTICS INC-A (CTNM) at the end of Q3 2026, worth $5.2M. The largest holder was Adar1 Capital Management, with 0.2% of its portfolio. Perceptive Advisors sold out of its position this quarter.
Holders · Q3 2026
1
New holders
0
Value held
$5.2M
Quarter-end price (est.)
$13.42
Investors holding CTNM · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.22% | 384,890 | $5.2M | ADD+38.0% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Perceptive Advisors | 0.31% | 1,255,592 | $20.6M | EXIT |